Patents by Inventor James P. McCarthy
James P. McCarthy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20180028666Abstract: Compositions and methods for treating disordered tissues, such as caused by pathogens and/or by toxins. The treatment compositions include an anti-infective active agent, a liquid carrier, and benzocaine in an amount so that the treatment composition penetrates more quickly into disordered tissue compared to the treatment composition in the absence of the benzocaine. In addition, the benzocaine can increase residence time of the anti-infective active in the treatment area. The preferred anti-infective active agent can be an organohalide, such as a quaternary ammonium halide compound, an example of which is benzalkonium chloride. The treatment compositions and methods may employ the use of an applicator adapted for use in promoting penetration of the treatment composition and/or agitation of the disordered tissue to further enhance penetration.Type: ApplicationFiled: June 21, 2017Publication date: February 1, 2018Inventors: B. Ron Johnson, James P. McCarthy
-
Patent number: 9495594Abstract: A methodology for detecting image anomalies in a target area for classifying objects therein, in which at least two images of the target area are obtained from a sensor representing different polarization components. The methodology can be used to classify and/or discriminate manmade objects from natural objects in a target area, for example. A data cube is constructed from the at least two images with the at least two images being aligned, such as on a pixel-wise basis. A processor computes the global covariance of the data cube and thereafter locates a test window over a portion of the data cube. The local covariance of the contents of the test window is computed and objects are classified within the test window when an image anomaly is detected in the test window. For example, an image anomaly may be determined when a matrix determinant ratio of the local covariance and the global covariance exceeds a probability ratio threshold. The window can then be moved, e.g.Type: GrantFiled: June 5, 2014Date of Patent: November 15, 2016Assignee: The United States of America as represented by the Secretary of the ArmyInventors: Dalton S. Rosario, Joao M. Romano, James P. McCarthy
-
Patent number: 9314526Abstract: Compositions and methods for treating disordered tissues, such as caused by pathogens and/or by toxins. The treatment compositions include an anti-infective active agent, a liquid carrier, and benzocaine in an amount so that the treatment composition penetrates more quickly into disordered tissue compared to the treatment composition in the absence of the benzocaine. In addition, the benzocaine can increase residence time of the anti-infective active in the treatment area. The preferred anti-infective active agent can be an organohalide, such as a quaternary ammonium halide compound, an example of which is benzalkonium chloride. The treatment compositions and methods may employ the use of an applicator adapted for use in promoting penetration of the treatment composition and/or agitation of the disordered tissue to further enhance penetration.Type: GrantFiled: August 22, 2014Date of Patent: April 19, 2016Assignee: QUADEX PHARMACEUTICALS, LLCInventors: B. Ron Johnson, James P. McCarthy
-
Publication number: 20150023553Abstract: A methodology for detecting image anomalies in a target area for classifying objects therein, in which at least two images of the target area are obtained from a sensor representing different polarization components. The methodology can be used to classify and/or discriminate manmade objects from natural objects in a target area, for example. A data cube is constructed from the at least two images with the at least two images being aligned, such as on a pixel-wise basis. A processor computes the global covariance of the data cube and thereafter locates a test window over a portion of the data cube. The local covariance of the contents of the test window is computed and objects are classified within the test window when an image anomaly is detected in the test window. For example, an image anomaly may be determined when a matrix determinant ratio of the local covariance and the global covariance exceeds a probability ratio threshold. The window can then be moved, e.g.Type: ApplicationFiled: June 5, 2014Publication date: January 22, 2015Inventors: Dalton S. Rosario, Joao M. Romano, James P. McCarthy
-
Publication number: 20140364495Abstract: Compositions and methods for treating disordered tissues, such as caused by pathogens and/or by toxins. The treatment compositions include an anti-infective active agent, a liquid carrier, and benzocaine in an amount so that the treatment composition penetrates more quickly into disordered tissue compared to the treatment composition in the absence of the benzocaine. In addition, the benzocaine can increase residence time of the anti-infective active in the treatment area. The preferred anti-infective active agent can be an organohalide, such as a quaternary ammonium halide compound, an example of which is benzalkonium chloride. The treatment compositions and methods may employ the use of an applicator adapted for use in promoting penetration of the treatment composition and/or agitation of the disordered tissue to further enhance penetration.Type: ApplicationFiled: August 22, 2014Publication date: December 11, 2014Inventors: B. Ron Johnson, James P. McCarthy
-
Publication number: 20140364496Abstract: Compositions and methods for treating disordered tissues, such as caused by pathogens and/or by toxins. The treatment compositions include an anti-infective active agent, a liquid carrier, and benzocaine in an amount so that the treatment composition penetrates more quickly into disordered tissue compared to the treatment composition in the absence of the benzocaine. In addition, the benzocaine can increase residence time of the anti-infective active in the treatment area. The preferred anti-infective active agent can be an organohalide, such as a quaternary ammonium halide compound, an example of which is benzalkonium chloride. The treatment compositions and methods may employ the use of an applicator adapted for use in promoting penetration of the treatment composition and/or agitation of the disordered tissue to further enhance penetration.Type: ApplicationFiled: August 22, 2014Publication date: December 11, 2014Inventors: B. Ron Johnson, James P. McCarthy
-
Patent number: 8846725Abstract: Compositions and methods for treating disordered tissues, such as caused by pathogens and/or by toxins. The treatment compositions include an anti-infective active agent, a liquid carrier, and benzocaine in an amount so that the treatment composition penetrates more quickly into disordered tissue compared to the treatment composition in the absence of the benzocaine. In addition, the benzocaine can increase residence time of the anti-infective active in the treatment area. The preferred anti-infective active agent can be an organohalide, such as a quaternary ammonium halide compound, an example of which is benzalkonium chloride. The treatment compositions and methods may employ the use of an applicator adapted for use in promoting penetration of the treatment composition and/or agitation of the disordered tissue to further enhance penetration.Type: GrantFiled: January 24, 2011Date of Patent: September 30, 2014Assignee: Quadex Pharmaceuticals, LLCInventors: B. Ron Johnson, James P. McCarthy
-
Publication number: 20120190715Abstract: Compositions and methods for treating disordered tissues, such as caused by pathogens and/or by toxins. The treatment compositions include an anti-infective active agent, a liquid carrier, and benzocaine in an amount so that the treatment composition penetrates more quickly into disordered tissue compared to the treatment composition in the absence of the benzocaine. In addition, the benzocaine can increase residence time of the anti-infective active in the treatment area. The preferred anti-infective active agent can be an organohalide, such as a quaternary ammonium halide compound, an example of which is benzalkonium chloride. The treatment compositions and methods may employ the use of an applicator adapted for use in promoting penetration of the treatment composition and/or agitation of the disordered tissue to further enhance penetration.Type: ApplicationFiled: January 24, 2011Publication date: July 26, 2012Inventors: B. Ron Johnson, James P. McCarthy
-
Patent number: 7694119Abstract: Described are techniques for initializing a device in a data storage system. An indicator is set in an entry associated with a portion of the device indicating that the portion of the device is to be initialized. A signature field of the entry is set with a signature value indicating that the portion of the device is to be initialized. The device is indicated as available for use after setting the indicator and the signature field for each portion of the device. The device has one or more portions and each of the portions has a corresponding entry including an indicator and a signature field.Type: GrantFiled: March 30, 2006Date of Patent: April 6, 2010Assignee: EMC CorporationInventors: Michael J. Scharland, James P. McCarthy, Stephen R. Ives
-
Patent number: 6237772Abstract: An assembly of interconnected containers includes a plurality of containers each of which has an upper portion connected to a lower portion by a hinge or hinges with the upper portion having a pair of elongated generally parallel upwardly open channels. The container also has a pair of generally parallel generally downwardly projecting flanges structured to engage an upwardly open channel of an adjacent container and adjacent containers have either at least one of the channels engaged by a flange of an adjacent container or at least one of its flanges engaged in a channel of an adjacent container or both. The channels are preferably open having at least one end so as to permit relative sliding removal and insertion of the containers from and into the assembly. In another embodiment, a rail and flange structure is provided to interengage adjacent containers within an assembly. A container can also be provided that has a lid portion hingably attached to the upper portion of the container.Type: GrantFiled: October 12, 1999Date of Patent: May 29, 2001Assignee: Neotech Industries, Inc.Inventors: Paul E. LaMarche, Victor Golani, James P. McCarthy, James E. Smith, Gregory J. Thompson
-
Patent number: 5988463Abstract: A needle threader for yarn or other bulky materials that is used in needlework having a projecting loop provided with a substantial planar surface to accommodate the strands of the yarn and thereby reducing frictional resistance as the yarn is passed through the eye of the needle. The needle threader is provided with a cutter for the yarn on the same handle utilized by the threader.Type: GrantFiled: August 31, 1998Date of Patent: November 23, 1999Inventors: William L. DiCarlo, James P. McCarthy
-
Patent number: 5616758Abstract: A cationic silicone compound which can be employed in a variety of environments, such as a fiber lubricant, textile fabric softener, hair conditioner, and skin conditioner is formed from an aminosilicone compound which has the following Formula (I): ##STR1## wherein a, b, and c are 0-300;d is 0-4, preferably 1 or 2;R.sub.1 comprises hydrogen, an alkyl, aryl, alkynyl, alkenyl, alkyloxyalkylene group which may be unsubstituted or substituted with P, N, or S moieties;R.sub.2 is defined the same as R.sub.1 and can also be a carboxylic acid residue preferably a fatty acid residues, with the proviso that where R.sub.2 is a carboxylic acid residue, the R.sub.1 attached to the terminal N is hydrogen;R.sub.3 is defined the same as R.sub.2 and can also be alkoxy, aryloxy or oxyalkylene groups;R.sub.4 is defined the same as R.sub.3 and can also be an amino-substituted alkyl group;Z.sub.1 and Z.sub.Type: GrantFiled: June 6, 1995Date of Patent: April 1, 1997Assignee: Karlshamns ABInventors: James P. McCarthy, George H. Greene, Anthony G. DeWar
-
Patent number: 5542313Abstract: A Dual Radius Geometry Accelerator Control System is provided in which the throttle valve is made to open slowly during the off-idle range of operation then progressively faster during the mid-range operation until a maximum system actuation rate is reached. The throttle valve is then made to open at a gradually decreasing actuation rate until a local minimum actuation rate is reached at the point during the full throttle range of operation that downshifting occurs. Thereafter, the throttle valve is made to open at a substantially linear actuation rate as the control system approaches wide-open throttle.Type: GrantFiled: April 1, 1994Date of Patent: August 6, 1996Assignee: Chrysler CorporationInventor: James P. McCarthy
-
Patent number: 5474835Abstract: A cationic silicone compound which can be employed in a variety of environments, such as a fiber lubricant, textile fabric softener, hair conditioner, and skin conditioner is formed from an aminosilicone compound which has the following Formula (I): ##STR1## wherein a, b, and c are 0-300;d is 0-4, preferably 1 or 2;R.sub.1 comprises hydrogen, an alkyl, aryl, alkynyl, alkenyl, alkyloxyalkylene group which may be unsubstituted or substituted with P,N, or S moieties;R.sub.2 is defined the same as R.sub.1 and can also be a carboxylic acid residue preferably a fatty acid residues, with the proviso that where R.sub.2 is a carboxylic acid residue, the R.sub.1 attached to the terminal N is hydrogen;R.sub.3 is defined the same as R.sub.2 and can also be alkoxy, aryloxy or oxyalkylene groups;R.sub.4 is defined the same as R.sub.3 and can also be an amino-substituted alkyl group;Z.sub.1 and Z.sub.Type: GrantFiled: August 12, 1994Date of Patent: December 12, 1995Assignee: Karlshamns ABInventors: James P. McCarthy, George H. Greene, Anthony G. DeWar
-
Patent number: 5352817Abstract: A cationic silicone compound which can be employed in a variety of environments, such as a fiber lubricant, textile fabric softener, hair conditioner, and skin conditioner is formed from an aminosilicone compound which has the following Formula (I): ##STR1## wherein a, b, and c are 0-300; d is 0-4, preferably 1 or 2;R.sub.1 comprises hydrogen, an alkyl, aryl, alkynyl, alkenyl, oxyalkylene group which may be unsubstituted or substituted with P,N, or S moieties;R.sub.2 is defined the same as R.sub.1 and can also be a carboxylic acid residue preferably a fatty acid residues, with the proviso that where R.sub.2 is a carboxylic acid residue, the R.sub.1 attached to the terminal N is hydrogen;R.sub.3 is defined the same as R.sub.2 and can also be alkoxy, aryloxy or alkyloxyalkylene groups;R.sub.4 is defined the same as R.sub.3 and can also be an amino-substituted alkyl group;Z.sub.1 and Z.sub.Type: GrantFiled: November 16, 1992Date of Patent: October 4, 1994Assignee: Karlshamns ABInventors: James P. McCarthy, George H. Greene, Anthony G. DeWar
-
Patent number: 5164522Abstract: A cationic silicone compound which can be employed in a variety of environments, such as a fiber lubricant, textile fabric softener, hair conditioner, and skin conditioner.The cationic silicone is formed from an amino silicone compound which has the following Formula (I): ##STR1## wherein a, b, and c are 0-300; d is 0-4, preferably 1;R.sub.1 comprises hydrogen, an alkyl, aryl, alkynl, alkenyl, alkyloxyalkylene group which may be unsubstituted or substituted with P,N, or S moieties;R.sub.2 is defined the same as R.sub.1 and can also be a carboxylic acid residue preferably a fatty acid residues, with the proviso that where R.sub.2 is a carboxylic acid residue, the R.sub.1 attached to the terminal N is hydrogen;R.sub.3 is defined the same as R.sub.2 and can also be alkoxy, aryloxy or oxyalkylene groups;R.sub.4 is defined the same as R.sub.3 and can also be an amino-substituted alkyl group;Z.sub.1 and Z.sub.Type: GrantFiled: June 29, 1990Date of Patent: November 17, 1992Assignee: Karlshamns ABInventors: James P. McCarthy, George H. Greene, Anthony G. DeWar
-
Patent number: 4985271Abstract: The invention is a method for treating coffee beans to make a better-tasting and improved aroma coffee. Green coffee beans are first partially roasted to a Hunter a-color between about 3 and about 9, under roasting conditions sufficient to increase the Hunter a-color of the beans by at least about 1.5 a-color units during the partial roasting step. The partially roasted beans are then treated with either an alkaline solution comprising water and a foodgrade base, or a coffee bean extract solution comprising water and from about 1% to about 12% coffee solids. Preferably, the partially roasted beans are treated by soaking them in the solution at a temperature between about 65.degree. F. (18.degree. C.) and about 120.degree. F. (49.degree. C.) for a time between about 2 hours and about 24 hours.Type: GrantFiled: June 29, 1990Date of Patent: January 15, 1991Assignee: The Procter & Gamble CompanyInventors: Diane H. R. Neilson, Sara L. R. Work, Edward L. Whaley, Steven J. Kirkpatrick, James P. McCarthy
-
Patent number: 4919006Abstract: A limited slip viscous differential in which the housing therefor is gearingly connected with the drive axle and rotates therewith. Each of two output axles from the limited slip viscous differential is connected internally to a viscous coupling for transferring torque from the drive axle to at least one of the two output axles when at least one of the two output axles is rotating an angular velocity different from that of the housing. A structure is provided for releasably retaining each of the output axles within the housing.Type: GrantFiled: January 22, 1988Date of Patent: April 24, 1990Assignee: GKN Automotive, Inc.Inventors: Mark A. Willett, James P. McCarthy
-
Patent number: 4857351Abstract: The invention is a method for treating coffee beans to make a better-tasting and improved aroma coffee. Green coffee beans are first partially roasted to a Hunter a-color between about 3 and about 9, under roasting conditions sufficient to increase the Hunter a-color of the beans by at least about 1.5 a-color units during the partial roasting step. The partially roasted beans are then treated with either an alkaline solution comprising water and a foodgrade base, or a coffee bean extract solution comprising water and from about 1% to about 12% coffee solids. Preferably, the partially roasted beans are treated by soaking them in the solution at a temperature between about 65.degree. F. (18.degree. C.) and about 120.degree. F. (49.degree. C.) for a time between about 2 hours and about 24 hours.Type: GrantFiled: April 11, 1988Date of Patent: August 15, 1989Assignee: The Procter & Gamble CompanyInventors: Diane H. R. Neilson, Sara L. R. Work, Edward L. Whaley, Steven J. Kirkpatrick, James P. McCarthy
-
Patent number: 4560047Abstract: An electrical solenoid operates a three-way valve having a vent port, a port connected to a source of high pressure hydraulic fluid and a port connection to a pilot valve. A check valve supplied from a source of low pressure hydraulic fluid is connected to the cylinder of a clutch or servo of an automatic transmission when a pilot valve opens this communication upon energizing the solenoid coil. The clutch cylinder is depressurized through the pilot valve to the vent port of the solenoid-operated valve.Type: GrantFiled: August 4, 1982Date of Patent: December 24, 1985Assignee: Ford Motor CompanyInventors: James P. McCarthy, Richard E. Byler